Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Res. 2010 Jan 12;70(2):552–559. doi: 10.1158/0008-5472.CAN-09-2653

Table 4.

Comparison of MelaPRO probabilities with MELPREDICT probabilities and FH by reclassification rate. *

Carriers Noncarriers
MelaPRO-
HBI
MelaPRO-
HBI
MelaPRO-
HBI
MelaPRO-
HBI
Reclassication
Pr ≥.5 Pr < .5 Pr ≥ .5 Pr < .5 Rate**
MelaPRO-GEM
≥.5 16 1 7 6
<.5 0 5 0 160 4%
MELPREDICT
≥.5 4 0 3 2
< .5 12 6 4 164 9%
FH
+ 16 1 7 66
0 5 0 100 34%
*

MelaPRO-LBI is not included, as the study population does not apply.

Denotes a category where MelaPRO-HBI correctly classifies as compared to other methods.

The grey shading denotes a category where MelaPRO-HBI classifies differently as compared to other methods.

**

Reclassification rate is defined as the percentage of individuals that were classified differently by MelaPRO-HBI (categories † and ‡) as compared to the other models